Dual antiplatelet therapy is widely used for stent-assisted coil embolization (SACE) for unruptured intracranial aneurysms (UIAs) to prevent thromboembolic events (TEs). Compared to clopidogrel associated with aspirin, knowledge of the safety and efficacy of ticagrelor is lacking in large studies to date.
Methods
A retrospective cohort study was conducted from January 2016 to December 2018 with at least one year of follow-up in a single institution and systemic review.
Results
Altogether, 153 patients with UIA receiving SACE were separated into two groups: 113 patients receiving clopidogrel plus aspirin and 40 patients receiving ticagrelor plus aspirin. Acute in-stent thrombotic events were noted in two patients in the clopidogrel group (1.77%) and none in the ticagrelor group (0%). Additionally, one patient (0.88%) in the clopidogrel group had an early ischemic stroke (<3 months). Delayed ischemic stroke was noted in 6 patients (5.31%) in the clopidogrel group and 3 patients (7.50%) in the ticagrelor group. There were no major hemorrhagic events in either group. The two groups showed no significant differences with regard to ischemic stroke or hemorrhagic stroke.
Conclusion
Compared to the clopidogrel based regimen, ticagrelor can also reduce TEs without increasing bleeding tendency for SACE of UIAs. Ticagrelor combined with low-dose aspirin is a safe and effective alternative option for SACE.
JohnstonSCZhaoSDudleyRA, et al.Treatment of unruptured cerebral aneurysms in California. Stroke2001; 32: 597–605.
2.
HwangJSHyunMKLeeHJ, et al.Endovascular coiling versus neurosurgical clipping in patients with unruptured intracranial aneurysm: a systematic review. BMC Neurol2013; 12: 99.
3.
BirskiMWalesaCGacaW,et al.Clipping versus coiling for intracranial aneurysms. Neurol Neurochir Pol2014; 48: 122–129.
4.
AkpekSAratAMorsiH,et al.Self-expandable stent-assisted coiling of wide-necked intracranial aneurysms: a single-center experience. AJNR Am J Neuroradiol2005; 26: 1223–1231.
HongYWangYJDengZ,et al.Stent-assisted coiling versus coiling in treatment of intracranial aneurysm: a systematic review and meta-analysis. PLoS One2014; 9: e82311.
9.
BechanRSSprengersMEMajoieCB,et al.Stent-assisted coil embolization of intracranial aneurysms: complications in acutely ruptured versus unruptured aneurysms. AJNR Am J Neuroradiol2016; 37: 502–507.
10.
QureshiAILuftARSharmaM,et al.Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: part II--clinical aspects and recommendations. Neurosurgery2000; 46: 1360–1375.; discussion 1375–6.
11.
DerdeynCPCross 3rdDTmoranCJbrownGWpilgramTKdiringerMN., et al.Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg2002; 96: 837–843.
12.
TakigawaTSuzukiKSugiuraY, et al.Thromboembolic events associated with single balloon-, double balloon-, and stent-assisted coil embolization of asymptomatic unruptured cerebral aneurysms: evaluation with diffusion-weighted MR imaging. Neuroradiology2014; 56: 1079–1086.
13.
BrooksNPTurkASNiemannDB,et al.Frequency of thromboembolic events associated with endovascular aneurysm treatment: retrospective case series. J Neurosurg2008; 108: 1095–1100.
14.
AltayTKangHIWooHH, et al.Thromboembolic events associated with endovascular treatment of cerebral aneurysms. J Neurointerv Surg2011; 3: 147–150.
15.
GurbelPABlidenKP. Interpretation of platelet inhibition by clopidogrel and the effect of non-responders. J Thromb Haemost2003; 1: 1318–1319.
16.
SrinivasNR. Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?Eur J Drug Metab Pharmacokinet2009; 34: 147–150.
17.
CuissetTQuiliciJCohenW, et al.Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome. Am J Cardiol2011; 108: 760–765.
18.
CattaneoM. Ticagrelor versus clopidogrel in acute coronary syndromes. N Engl J Med2009; 361: 2386.; author reply 2387–8.
19.
GurbelPABlidenKPButlerK, et al.Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation2009; 120: 2577–2585.
20.
CannonCPHarringtonRAJamesS, et al.Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet2010: 375: 283–293.
21.
NarataAPAmelotABibiR, et al.Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms. Neurosurgery2019; 84: 77–83.
22.
BorchertRJSimonatoDHickmanCR, et al.P2y12 inhibitors for the neurointerventionalistInterv Neuroradiol2021; 15910199211015042.
23.
GuglielmiGVinuelaFDionJ,et al.Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: preliminary clinical experience. J Neurosurg1991; 75: 8–14.
24.
HanelRATausskyPDixonT, et al.Safety and efficacy of ticagrelor for neuroendovascular procedures. A single center initial experience. J Neurointerv Surg2014; 6: 320–322.
25.
KonoKShintaniAYoshimuraR, et al.Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms. Acta Neurochir2013; 155: 1549–1557.
26.
HwangGKimJGSongKS, et al.Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology2014; 273: 194–201.
27.
StarkeRMDurstCREvansA, et al.Endovascular treatment of unruptured wide-necked intracranial aneurysms: comparison of dual microcatheter technique and stent-assisted coil embolization. J Neurointerv Surg2015; 7: 256–261.
28.
MatsumotoYNakaiKTsutsumiM, et al.Onset time of ischemic events and antiplatelet therapy after intracranial stent-assisted coil embolization. J Stroke Cerebrovasc Dis2014; 23: 771–777.
29.
SongJYeonJYKimJS,et al.Delayed thromboembolic events more than 30 days after self expandable intracranial stent-assisted embolization of unruptured intracranial aneurysms. Clin Neurol Neurosurg2015; 135: 73–78.
30.
MatsumotoYIkoMTsutsumiM, et al.The safety and efficacy of triple antiplatelet therapy after intracranial stent-assisted coil embolization. J Stroke Cerebrovasc Dis2015; 24: 1513–1519.
31.
HaEJChoWSKimJE, et al.Prophylactic antiplatelet medication in endovascular treatment of intracranial aneurysms: low-dose prasugrel versus clopidogrel. AJNR Am J Neuroradiol2016; 37: 2060–2065.
32.
ParkJCLeeDHKimJK, et al.Microembolism after endovascular coiling of unruptured cerebral aneurysms: incidence and risk factors. J Neurosurg2016; 124: 777–783.
33.
SongJShinYS. Antiplatelet drug resistance did not increase the thromboembolic events after stent-assisted coiling of unruptured intracranial aneurysm: a single center experience of 99 cases. Neurol Sci2017; 38: 879–885.
34.
SedatJChauYGaudartJ,et al.Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms. Interv Neuroradiol2017; 23: 52–59.
35.
ChoiHHLeeJJChoYD, et al.Antiplatelet premedication for stent-assisted coil embolization of intracranial aneurysms: low-dose prasugrel vs clopidogrel. Neurosurgery2018; 83: 981–988.
36.
KimMSParkESParkJB,et al.Clopidogrel response variability in unruptured intracranial aneurysm patients treated with stent-assisted endovascular coil embolization: is follow-up clopidogrel response test necessary?J Korean Neurosurg Soc2018; 61: 201–211.
37.
SoizeSFoussierCManceauPF, et al.Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter/disrupter: a matched-cohort study comparing clopidogrel with ticagrelor. J Neuroradiol2019; 46: 378–383.
38.
KimMSJoKIYeonJY, et al.Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis. Neuroradiology2016; 58: 1125–1134.
39.
HustedSvan GiezenJJ. Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonistCardiovasc Ther2009; 27: 259–274.
